Syros Pharmaceuticals, Inc. 4/A SEC Filings

Filed On	Filing
20 Apr 2023	Form 4/A: Tyson Timothy, Director Received 8,257 shares as a grant or award · Granted 33,554 Stock Option (right to buy)
20 Apr 2023	Form 4/A: Akkaraju Srinivas, Director Received 691,489 shares as a grant or award · Granted 12,000 Stock Option (right to buy) · Granted 8,000 Restricted Stock Units · 1 more
11 Oct 2022	Form 4/A: Chee Conley, Chief Commercial Officer Granted 44,500 Stock Option (right to buy) · Granted 34,000 Restricted Stock Units
10 Feb 2021	Form 4/A: Young Richard A, Director Sold 633 shares ($5.68K) · Sold 5,357 shares ($46.9K)
21 Dec 2020	Form 4/A: Quirk Gerald E, Chief Legal & Admin. Officer Granted 35,000 Stock Option (right to buy)
22 Sep 2017	Form 4/A: Nelsen Robert, Director Granted 11,000 Stock Option (right to buy)
22 Sep 2017	Form 4/A: Young Richard A, Director Granted 11,000 Stock Option (right to buy)
22 Sep 2017	Form 4/A: Sharp Philip A, Director Granted 11,000 Stock Option (right to buy)
22 Sep 2017	Form 4/A: Sato Vicki L, Director Granted 11,000 Stock Option (right to buy)
22 Sep 2017	Form 4/A: Patel Sanj K, Director Granted 11,000 Stock Option (right to buy)
22 Sep 2017	Form 4/A: Nashat Amir, Director Granted 11,000 Stock Option (right to buy)
22 Sep 2017	Form 4/A: Fanucci Marsha, Director Granted 11,000 Stock Option (right to buy)
22 Sep 2017	Form 4/A: Akkaraju Srinivas, Director Granted 22,000 Stock Option (right to buy)

Comments